TD Cowen Maintains Astria Therapeutics Inc(ATXS.US) With Buy Rating, Maintains Target Price $35

Moomoo NewsNov 20 07:33 ET · Ratings

Astria Therapeutics (NASDAQ:ATXS) Is In A Good Position To Deliver On Growth Plans

Simply Wall StNov 18 08:36 ET

A Quick Look at Today's Ratings for Astria Therapeutics Inc(ATXS.US), With a Forecast Between $23 to $35

Moomoo NewsNov 15 08:00 ET · Ratings

12 Health Care Stocks Moving In Thursday's Pre-Market Session

BenzingaNov 14 16:10 ET

Astria Therapeutics Analyst Ratings

BenzingaNov 14 08:16 ET · Ratings

Express News | Astria Therapeutics : Oppenheimer Raises Target Price to $28 From $26

ReutersNov 14 08:07 ET